BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2159305)

  • 1. Mechanism of inactivation of myeloperoxidase by propylthiouracil.
    Lee E; Miki Y; Katsura H; Kariya K
    Biochem Pharmacol; 1990 May; 39(9):1467-71. PubMed ID: 2159305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between leukopenia and bone marrow myeloperoxidase in the rat treated with propylthiouracil.
    Kariya K; Lee E; Hirouchi M
    Jpn J Pharmacol; 1984 Oct; 36(2):217-22. PubMed ID: 6096612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure.
    Lee E; Hirouchi M; Hosokawa M; Sayo H; Kohno M; Kariya K
    Biochem Pharmacol; 1988 Jun; 37(11):2151-3. PubMed ID: 2837228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative metabolism of propylthiouracil by peroxidases from rat bone marrow.
    Lee E; Miki Y; Hosokawa M; Sayo H; Kariya K
    Xenobiotica; 1988 Oct; 18(10):1135-42. PubMed ID: 2853896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide.
    Kettle AJ; Gedye CA; Winterbourn CC
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):503-8. PubMed ID: 9020887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selenium analog of 6-propylthiouracil. Measurement of its inhibitory effect on type I iodothyronine deiodinase and of its antithyroid activity.
    Taurog A; Dorris ML; Hu WX; Guziec FS
    Biochem Pharmacol; 1995 Mar; 49(5):701-9. PubMed ID: 7887985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.
    Taurog A; Dorris ML
    Endocrinology; 1989 Jun; 124(6):3038-42. PubMed ID: 2656250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatic glutathione transferases by propylthiouracil and its metabolites.
    Kariya K; Sawahata T; Okuno S; Lee E
    Biochem Pharmacol; 1986 May; 35(9):1475-9. PubMed ID: 3707612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A; Taurog A; Engler H; Dorris ML
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
    Zhang AH; Chen M; Gao Y; Zhao MH; Wang HY
    Clin Immunol; 2007 Feb; 122(2):187-93. PubMed ID: 17070108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine 5'-deiodinase activity of rat kidney: observations on activation by thiols and inhibition by propylthiouracil.
    Leonard JL; Rosenberg IN
    Endocrinology; 1978 Dec; 103(6):2137-44. PubMed ID: 748037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inactivation of thyroid peroxidase by thioureylene drugs.
    Engler H; Taurog A; Nakashima T
    Biochem Pharmacol; 1982 Dec; 31(23):3801-6. PubMed ID: 6186257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
    Taurog A; Dorris ML; Guziec FS; Uetrecht JP
    Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolites of [2-14C]propylthiouracil in rat thyroid.
    Lindsay RH; Kelly K; Hill JB
    Endocrinology; 1979 Jun; 104(6):1686-97. PubMed ID: 221188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodothyronine 5'-deiodination in rat kidney microsomes: sensitivity to propylthiouracil.
    Goswami A; Rosenberg IN
    Endocrinology; 1988 Dec; 123(6):2774-81. PubMed ID: 3197644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of the effect of propylthiouracil and ronnel on thyroxine-5'-monodeiodinase activity in steers.
    Kahl S; Bitman J; Rumsey TS
    J Anim Sci; 1985 Jul; 61(1):197-202. PubMed ID: 2411706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of myeloperoxidase with diclofenac. Inhibition of the chlorinating activity of myeloperoxidase by diclofenac and oxidation of diclofenac to dihydroxyazobenzene by myeloperoxidase.
    Zuurbier KW; Bakkenist AR; Fokkens RH; Nibbering NM; Wever R; Muijsers AO
    Biochem Pharmacol; 1990 Oct; 40(8):1801-8. PubMed ID: 2173589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of gastric peroxidase by mercaptomethylimidazole.
    Bandyopadhyay U; Bhattacharyya DK; Banerjee RK
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):79-84. PubMed ID: 8250859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.
    Ye H; Zhao MH; Gao Y; Guo XH; Wang HY
    Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.